{
  "meta": {
    "title": "Nucleotide_Synthesis_And_Catabolism_And_Related_Diseases",
    "url": "https://brainandscalpel.vercel.app/nucleotide-synthesis-and-catabolism-and-related-diseases-f580463a.html",
    "scrapedAt": "2025-11-30T11:11:48.977Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">N-glycosidic bond</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">O-glycosidic bond</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphodiester bond</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrogen bond</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Nucleosides are derivatives of purines and pyrimidines that have a sugar linked to a ring nitrogen of a purine or pyrimidine. A bond between sugar and a nitrogen base is:</span></p>",
      "unique_key": "DT1182307",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182307,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>N Base (purine or pyrimidine) is attached to a pentose sugar (ribose or deoxyribose) by the <strong>glycosidic bond</strong>.</p>\n<ul>\n<li>C1 of sugar is linked to N1 of pyrimidine or N9 of purine. Because the bond involves a nitrogen atom on the base, it is termed an <strong>N-glycosidic</strong><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904eb4e7f04-13df-4fc0-9007-ce65def22753.png\">\n</li>\n</ul>\n<p>If the <strong>carbon</strong> of sugar forms a bond with the<strong> oxygen</strong> atom in the hydroxyl group, the bond formed is an <strong>O-glycosidic bond (Option B)</strong>. It is not found in nucleosides.</p>\n<p>Phosphodiester bond <strong>(Option C)</strong> joins the 3' hydroxyl group of deoxyribose of one nucleotide to the 5' hydroxyl group of another nucleotide through a phosphate group. All deoxyribonucleotides are linked together by 3'- 5' phosphodiester bonds in the DNA strand.</p>\n<p>The Nitrogen bases of one strand are paired with complementary Nitrogen bases of the second strand during the formation of double-stranded DNA. Such base pairs are held together by Hydrogen bonds. <strong>(Option D) </strong></p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a nucleotide</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Excreted unchanged in urine during degradation of transfer RNA</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Ribose attach to N1 of uracil</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Bond between sugar and N base is beta N glycosidic bond</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true about pseudouridine?</span></p>",
      "unique_key": "DT1182310",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182310,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Pseudouridine is excreted unchanged in the urine since there is no human enzyme that can hydrolyze or break it.</p>\n<ul>\n<li>Pseudouridine is a <strong>nucleoside</strong>, not a nucleotide. <strong>(Option A)</strong></li>\n<li>The nucleotide form, pseudouridylic acid (&psi;), is formed by rearrangement of uridine monophosphate (UMP) in preformed tRNA.</li>\n<li>Pseudouridine is present in transfer RNA.</li>\n<li>There is no human enzyme that can hydrolyze or break pseudouridine. As a result, it is excreted <strong>unchanged in the urine</strong> during tRNA degradation.</li>\n<li>In pseudouridine, the sugar (D-ribose) attaches to the <strong>C-5 position of uracil</strong>. <strong>(Option C)</strong></li>\n<li>This forms a <strong>carbon-carbon bond</strong>, not the usual nitrogen-carbon bond.</li>\n<li>Most nucleosides have a <strong>&beta;-N-glycosidic bond</strong> linking the sugar to N-1 of pyrimidines or N-9 of purines.</li>\n<li>In pseudouridine, the bond is <strong>not a &beta;-N-glycosidic bond</strong> but a carbon-carbon bond. <strong>(Option D)</strong></li>\n<li>The end product of pyrimidine catabolism (like uracil) is <strong>&beta;-alanine</strong> or <strong>&beta;-aminoisobutyrate</strong>. <strong>&beta;-aminoisobutyrate</strong> is excreted in the urine.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904b1bd2f24-485e-4e8b-8839-b97155053a2f.png\">\n</li>\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">The six atom ring of purine is numbered clockwise</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">The atoms of the pyrimidine ring are numbered anticlockwise</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Many coenzymes are derivatives of adenine nucleotides</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleotides are positively charged at physiological pH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements regarding nucleotides is correct?</span></p>",
      "unique_key": "DT1182319",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182319,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Many Coenzymes and related compounds are derivatives of Adenosine Monophosphate, for example:</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509041fd9e1ae-ddda-4c8d-b2cb-2d628789adc3.png\">\n<p>Purines and pyrimidines are nitrogen-containing heterocycles, cyclic structures that contain, in addition to carbon, other (hetero) atoms such as nitrogen. Their six-atom rings in <strong>purines are numbered in an anticlockwise direction</strong>, whereas in <strong>pyrimidine rings are numbered in a clockwise direction. (Option A &amp; B ruled out)</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250904f709d876-a47b-4162-9dc6-7a8438027d19.png\">\n<p>The primary and secondary phosphoryl groups of nucleosides have pKa values of about 1.0 and 6.2, respectively. Nucleotides, therefore, bear a significant <strong>negative</strong> charge at physiologic pH. <strong>(Option D ruled out)</strong></p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Dietary intake</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">De novo Synthesis</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphorylation of purines</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphorylation of purine nucleosides</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The major process that produces purine nucleotide for the synthesis of DNA during cell division is:</span></p>",
      "unique_key": "DT1182324",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182324,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>During de novo synthesis in tissue, purine or pyrimidine nucleotides are produced from various amphibolic intermediates.</li>\r\n<li>De novo synthesis is a major pathway that provides nucleotides to tissues to meet their physiological demands.</li>\r\n<li>The three processes that contribute to purine nucleotide biosynthesis are, in order of decreasing importance:\r\n<ul>\r\n<li>Synthesis from amphibolic intermediates (synthesis de novo)</li>\r\n<li>Phosphoribosylation of purines</li>\r\n<li>Phosphorylation of purine nucleosides</li>\r\n</ul>\r\n</li>\r\n<li>All dietary nucleic acids and nucleotides are nonessential; they will not be incorporated into tissue nucleic acids.</li>\r\n<li>Following ingestion of nucleotide or nucleic acid in the diet, their degradation results in mononucleotides, which may be absorbed or converted to purine and pyrimidine bases.</li>\r\n<li>The purine bases are then oxidised to uric acid, which may be absorbed and excreted in the urine.</li>\r\n<li>Pyrimidine bases are degraded into CO<sub>2</sub>, NH<sub>3</sub>, beta-alanine, and beta-aminoisobutyrate.<strong> (Option A Ruled out) </strong></li>\r\n<li>During phosphorylation of purines, there is an addition of ribose phosphate to preformed purine or pyrimidine bases. <strong>(Option C Ruled out) </strong></li>\r\n<li>During phosphorylation of purine nucleosides, there is an addition of phosphate to the nucleoside. <strong>(Option D Ruled out) </strong></li>\r\n<li>Both phosphorylation of purines and phosphorylation of purine nucleosides occur during the salvage pathway. Such purine or pyrimidine bases or purine nucleosides are derived from the damaged DNA of broken-down cells (recycled).</li>\r\n</ul>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">CO<sub>2</sub></span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycine</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During de novo synthesis, purine N base is produced from various amphibolic intermediates. Which will be the source of C6 of the purine ring (as shown in the image below) during de novo synthesis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509042d52fe1a-a3dc-441d-8f27-2c7d1b57ede7.png\"></span></p>",
      "unique_key": "DT1182327",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182327,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In the de novo pathway, respiratory CO2 contributes the carbon at position 6 of the purine ring.</li>\n<li>De novo synthesis is a major pathway that provides nucleotides to tissues to meet their physiological demands. During de novo synthesis in tissue, purine or pyrimidine nucleotides are produced from various amphibolic intermediates.</li>\n</ul>\n<p>Sources of the nitrogen and carbon atoms of the purine ring:</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090441b8e693-a21b-41dc-bed2-d7a6cb00d0d1.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p>Glycine <strong>(Option B)</strong> provides C4, C5, and N7 of purine rings.</p>\n<p>Folic acid (Tetrahydrofolate) <strong>(Option C) </strong>provides C2 &amp; C8 of purine rings.</p>\n<p>Glutamine <strong>(Option D) </strong>provides N3 and N9 of purine rings.</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Amidotransferase</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">PRPP glutamyl amidotransferase</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Formyl transferase</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">IMP dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mycophenolic acid inhibits which of the following enzymes of purine biosynthesis?</span></p>",
      "unique_key": "DT1182330",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182330,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Mycophenolic acid is a selective, noncompetitive inhibitor of<strong> IMP (inosine monophosphate) dehydrogenase</strong>, the rate-limiting enzyme that converts IMP to XMP (Xanthosine Monophosphate) in the guanine nucleotide synthesis pathway.</li>\r\n<li>Mycophenolic acid is a drug used to prevent organ rejection in adult patients who have received kidney transplants.</li>\r\n<li>Many antifolate drugs &amp; glutamine analogues block purine nucleotide biosynthesis by inhibiting a particular enzyme in the de novo biosynthesis pathway.</li>\r\n<li>Antifolate drugs like methotrexate inhibit the enzyme dihydrofolate reductase, reducing the synthesis of tetrahydrofolate. So, antifolate drugs stop reactions in which the carbons are contributed by derivatives of tetrahydrofolate. Such compounds that inhibit the formation of tetrahydrofolate and therefore block purine synthesis have been used in cancer chemotherapy.</li>\r\n</ul>\r\n<p><strong>Other inhibitory compounds that inhibit various enzymes and reactions of purine biosynthesis are:</strong></p>\r\n<ul>\r\n<li>Azaserine (inhibits the reaction catalysed by amidotransferase) <strong>(Option A)</strong></li>\r\n<li>Diazanorleucine (inhibits PRPP glutamine amidotransferase enzyme), 6-mercaptopurine (inhibits Adenyosuccinase and IMP dehydrogenase enzyme) <strong>(Option B)</strong></li>\r\n<li>Mycophenolic acid (inhibits IMP dehydrogenase enzyme)</li>\r\n</ul>\r\n<p><strong>Formyl transferase (Option C): </strong>This is anenzyme that add formyl groups during purine synthesis (e.g., transforming GAR to FGAR). This is not the target of mycophenolic acid.</p>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycine</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamic acid</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Alanine</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspartic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which amino acid is involved in the de novo synthesis of both purine and pyrimidine?</span></p>",
      "unique_key": "DT1182333",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182333,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Aspartic acid provides N1 of the purine ring and C4, C5, C6 &amp; N1 of the pyrimidine ring. So it is involved in the synthesis of both purine and pyrimidine.</li>\n</ul>\n<p><strong>Sources of the nitrogen and carbon atoms of the purine ring: </strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090405f9b42d-206a-4216-b20d-3373f24221e7.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glycine</strong> (<strong>Option A) </strong>is involved only in purine nucleotide synthesis. It provides C4, C5, and N7 of purine rings.</p>\n<p><strong>Glutamic</strong> <strong>acid</strong> (<strong>Option B)</strong> is not involved in purine and pyrimidine biosynthesis, but <strong>glutamine</strong> is involved in both purine and pyrimidine biosynthesis.</p>\n<p><strong>Alanine</strong> (<strong>Option C) </strong>does not take part in the synthesis of purine and pyrimidine.</p>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Ascorbic acid</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridoxine</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitriol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following vitamin deficiencies can lead to purine deficiency states in humans?</span></p>",
      "unique_key": "DT1182335",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182335,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Purine deficiency states, while rare in humans, generally occur due to a deficiency of folic acid.</li>\n<li>C2 of the purine ring is contributed by N10 formyl tetrahydrofolate, whereas C8 of the purine ring is contributed by N5 N10 methenyl tetrahydrofolate. So derivatives of tetrahydrofolate, which are produced from folic acid, play an important role in the de novo biosynthesis of purine nucleotides.</li>\n</ul>\n<p><strong>Sources of the nitrogen and carbon atoms of the purine ring:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509045682c64a-5d4c-4943-90a7-23a94bf51f19.png\">\n<p>So, any compounds that inhibit the formation of tetrahydrofolate and therefore block purine synthesis have been used in cancer chemotherapy to inhibit DNA replication in rapidly dividing cells.</p>\n<p><strong>Explanation of other options: </strong></p>\n<p><strong>Ascorbic acid (Vitamin C)</strong> <strong>(Option A)</strong> deficiency can lead to scurvy. It is not involved in purine biosynthesis reactions.</p>\n<p><strong>Pyridoxine</strong> <strong>(Option C)</strong> has no role in purine biosynthesis.</p>\n<p><strong>Calcitriol (Vitamin D)</strong> <strong>(Option D) </strong>also has no role in purine biosynthesis. Vitamin D deficiency can lead to rickets.</p>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Concentration of PRPP determines the rate of purine biosynthesis</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Distinct multifunctional enzymes catalyse the reactions</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">The brain depends on de novo synthesis to produce purine nucleotides</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Energetically very costly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are true regarding de novo purine biosynthesis, except:</span></p>",
      "unique_key": "DT1182337",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182337,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Human brain tissue has a low level of PRPP glutamyl amidotransferase, an enzyme involved in de novo synthesis. <strong>So the brain depends on a salvage pathway to produce purine nucleotides.</strong></li>\r\n<li><strong>The overall determinant of the rate of de novo purine nucleotide biosynthesis is the concentration of PRPP. </strong>This, in turn, depends on the rate of PRPP synthesis, utilization, degradation, and regulation.</li>\r\n<li>The rate of PRPP synthesis depends on the availability of ribose 5-phosphate and on the activity of PRPP synthetase, an enzyme whose activity is feedback inhibited by AMP, ADP, GMP, and GDP.</li>\r\n<li>Elevated levels of these nucleoside phosphates thus signal a physiologically appropriate overall decrease in their biosynthesis. <strong>(Option A is true)</strong></li>\r\n<li><strong>Multifunctional Catalysts Participate in Purine Nucleotide Biosynthesis</strong>. The enzymes of eukaryotes are polypeptides that possess multiple catalytic activities whose adjacent catalytic sites facilitate channelling of intermediates between sites. Three distinct multifunctional enzymes catalyze reactions differently. <strong>(Option B is true)</strong></li>\r\n<li><strong>Purine nucleoside biosynthesis is energetically costly.</strong> In addition to ATP, glycine, glutamine, aspartate, and reduced tetrahydrofolate derivatives are all consumed. Thus, it is of survival advantage to closely regulate purine biosynthesis in response to varying physiological needs. <strong>(Option D is true)</strong></li>\r\n</ul>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine monophosphate (AMP)</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Guanosine monophosphate (GMP)</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Inosine monophosphate (IMP)</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Xanthosine monophosphate (XMP)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The first purine nucleotide synthesised by de novo biosynthesis is:</span></p>",
      "unique_key": "DT1182341",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182341,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Inosine monophosphate (IMP)</strong> is the initial purine nucleotide produced by the de novo pathway, serving as the central branching point for all subsequent purine nucleotide synthesis.</li>\n<li>IMP then serves as the branch point:\n<ul>\n<li><strong>IMP &rarr; AMP</strong> via adenylosuccinate synthase and lyase</li>\n<li><strong>IMP &rarr; XMP &rarr; GMP</strong> via IMP dehydrogenase and GMP synthetase</li>\n</ul>\n</li>\n<li>PRPP (Phosphoribosyl Pyrophosphate) provides the ribose-phosphate scaffold, upon which the purine ring is built stepwise to form IMP.</li>\n<li>Subsequent amination and phosphorylation steps yield the end-product nucleotides AMP and GMP.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090407baf98a-0a6c-4397-b1e3-7be9a840a0c2.png\">\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Adenosine monophosphate (AMP) (Option A)</strong> is formed by the amination of IMP via the adenylosuccinate synthase/lyase sequence, not as the primary de novo product.</p>\n<p><strong>Guanosine monophosphate (GMP) (Option B)</strong> is synthesised in two steps from IMP - first to XMP by IMP dehydrogenase, then to GMP by GMP synthetase.</p>\n<p><strong>Xanthosine monophosphate (XMP) (Option D)</strong> is an intermediate in the pathway from IMP to GMP and is not the initial purine nucleotide produced.</p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Orotate monophosphate (OMP)</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Uridine monophosphate (UMP)</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Deoxy uridine monophosphate (dUMP)</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Thymidine monophosphate (TMP)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The first pyrimidine nucleotide synthesised by de novo biosynthesis is:</span></p>",
      "unique_key": "DT1182346",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182346,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>During de novo pyrimidine biosynthesis, the first nucleotide synthesised is Orotate monophosphate (OMP).</li>\n<li>Then OMP&rarr;UMP&rarr;UDP (uridine diphosphate)&rarr; UTP (uridine triphosphate)&rarr;CTP (cytidine triphosphate)</li>\n<li>Also UMP&rarr;UDP&rarr;dUDP&rarr;dUMP&rarr;TMP</li>\n<li>OMP <strong>(Option A)</strong> is produced first during de novo synthesis.</li>\n<li>UMP <strong>(Option B) </strong>is produced from OMP.</li>\n<li>dUMP <strong>(Option C)</strong> is produced from UMP.</li>\n<li>(Option D) TMP is also produced from UMP</li>\n<li>De novo biosynthesis of pyrimidine nucleotide reactions:<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090483e06574-8d08-4e29-b992-b6104a3b85e4.png\">\n</li>\n</ul>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Purine metabolism</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyrimidine metabolism</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein metabolism</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine metabolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presented with pain and swelling in the great toe. On blood investigation, his uric acid level is found to be 9 mg/dl (normal 3.5 to 7 mg/dl). This clinical condition is associated with defects in which of the following metabolic processes?</span></p>",
      "unique_key": "DT1182359",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182359,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The given condition points to the diagnosis of gout, which is caused by a defect in purine metabolism.</p>\r\n<ul>\r\n<li>Gout is a metabolic disorder caused by hyperuricemia.</li>\r\n<li>Due to the low solubility of uric acid in water, it will get deposited in the synovial joint, leading to <strong>arthritis</strong>.</li>\r\n<li>Uric acid is an <strong>end product</strong> of <strong>purine nucleotide</strong> At physiological pH, uric acid is mostly ionised and present in plasma as sodium urate.</li>\r\n<li>Insoluble urate crystals precipitate in synovial fluid and other tissues, triggering intense inflammation.</li>\r\n<li><strong>Epidemiology:</strong> More common in middle-aged men; risk rises with age, obesity, and a high-purine diet.</li>\r\n<li><strong>Clinical features:</strong>\r\n<ul>\r\n<li>Acute onset of severe pain, erythema, and swelling - often of the first metatarsophalangeal joint (\"podagra\").</li>\r\n<li>Chronic tophaceous gout may develop tophi in soft tissues.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Risk factors:</strong>\r\n<ul>\r\n<li>High alcohol intake</li>\r\n<li>Red meat/seafood consumption</li>\r\n<li>Renal insufficiency</li>\r\n<li>Diuretic use</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Pyrimidine metabolism(Option B): </strong>The end product of pyrimidine catabolism is highly water-soluble, so overproduction of pyrimidine catabolites is rarely associated with clinical disease. Defects in pyrimidine nucleotide synthesis can lead to orotic aciduria.</p>\r\n<p><strong>Protein metabolism (Option C) </strong>The end product of protein catabolism is urea. Any defect in protein catabolism can lead to increased or decreased urea levels in the blood. Urea cycle defects can lead to hyperammonemia.</p>\r\n<p><strong>Phenylalanine metabolism (Option D): </strong>A defect in phenylalanine catabolism can lead to phenylketonuria.</p>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Defect in PRPP synthase enzyme</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Lesch Nyhan syndrome</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Leukemia</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactic acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions can cause elevated blood uric acid levels while showing reduced or absent uric acid excretion in the urine?</span></p>",
      "unique_key": "DT1182362",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182362,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>In lactic acidosis, accumulated lactate competes with urate for renal tubular secretion, reducing uric acid excretion.</li>\r\n<li>This competition causes <strong>hyperuricemia</strong> despite <strong>low or absent uricosuria</strong>.</li>\r\n<li>Uric acid is an end product of purine nucleotide degradation. It is excreted by the kidneys. The daily excretion of uric acid is around 600 mg.</li>\r\n<li>Normal level of uric acid in blood is 3 to 7 mg/dl in males &amp; 2-6 mg/dl in females (lower in females compared to males)</li>\r\n<li>Hyperuricemia is an increased level of uric acid in the blood (more than 7mg/dl). It may or may not be associated with increased excretion of uric acid in urine (uricosuria)</li>\r\n<li>Causes of Hyperuricemia &amp; Gout-May be:\r\n<ul>\r\n<li><strong>Primary:</strong> Inborn error of metabolism which leads to overproduction of purines, which leads to increased purine catabolism, leading to overproduction of uric acid</li>\r\n<li><strong>Secondary:</strong> Secondary to other disorders, which lead to either overproduction of uric acid or reduced excretion of uric acid</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Defect in PRPP synthase enzyme (Option A): </strong>PRPP enzyme activity is abnormally increased. PRPP synthase is <strong>overactive</strong> and lacks feedback inhibition &rarr; &uarr; PRPP &rarr; &uarr; de novo purine synthesis &rarr; &uarr; uric acid production and &uarr; uricosuria.</p>\r\n<p><strong>Lesch&ndash;Nyhan syndrome (Option B) </strong>occurs due to a defect in the HGPRT (Hypoxanthine guanine phosphoribosyl transferase) enzyme of the purine salvage pathway. <strong>HGPRT loss</strong> &rarr; &darr; salvage, &uarr; PRPP &rarr; &uarr; purine synthesis and catabolism &rarr; hyperuricemia <strong>with</strong> &uarr; uricosuria.</p>\r\n<p><strong>Leukaemia (Option C) </strong>is a blood cancer, characterised by excessive cell turnover. <strong>High cell turnover</strong> &rarr; excessive nucleic acid degradation &rarr; &uarr; purine breakdown to uric acid &rarr; hyperuricemia <strong>with</strong> elevated urinary excretion.</p>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Xanthine oxidase</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">HGPRTase</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Urease</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Uricase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Allantoin is a more water-soluble product of purine catabolism compared to uric acid. But in humans, uric acid is not further converted into allantoin due to a lack of the enzyme:</span></p>",
      "unique_key": "DT1182364",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182364,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Uricase</strong> (urate oxidase) catalyses the oxidation of uric acid to <strong>allantoin</strong>, which is highly water-soluble.</li>\r\n<li>Humans <strong>lack</strong> uricase, so uric acid remains the end product of purine catabolism.</li>\r\n<li>Lack of uricase in humans contributes to susceptibility to <strong>gout</strong> and uric acid kidney stones.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Xanthine oxidase</strong> <strong>(Option A) </strong>enzyme converts Hypoxanthine into Xanthine and Xanthine into Uric acid. This enzyme is present in both mammals and humans, so both break down purines up to uric acid.</p>\r\n<p><strong>HGPRTase (Option B)</strong> is an enzyme involved in the salvage pathway. It converts Guanine &amp; Hypoxanthine into GMP &amp; IMP. Its deficiency can lead to Lesch-Nyhan syndrome.</p>\r\n<p><strong>Urease (Option C) </strong>catalyses the hydrolysis of Urea into ammonia and carbon dioxide. It is also not present in humans, so human urea is excreted in urine.</p>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose 6 phosphatase</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoxanthine guanine phosphoribosyl transferase</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine deaminase</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphoribosyl amido transferase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following enzyme defects can lead to hyperuricemia and gout, except:</span></p>",
      "unique_key": "DT1182366",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182366,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>ADA deficiency causes accumulation of adenosine and deoxyadenosine, leading to severe combined immunodeficiency (SCID) and hypouricemia, not hyperuricemia.</li>\r\n<li>Hyperuricemia arises from overproduction or underexcretion of uric acid, the end product of purine catabolism.</li>\r\n<li>Hypouricemia is clinically not significant.</li>\r\n<li><strong>Causes: </strong>\r\n<ul>\r\n<li>ADA deficiency</li>\r\n<li>XO deficiency</li>\r\n<li>Purine nucleoside phosphorylase deficiency</li>\r\n<li>PRPP Synthetase Deficiency</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options: </strong></p>\r\n<p>Deficiency of <strong>Glucose 6 Phosphatase</strong> <strong>(Option A)</strong> (Von Gierke's disease) leads to accumulation of glucose 6 phosphate (precursor of PRPP), which is diverted to the HMP shunt and increased ribose 5 phosphate, which increases de novo synthesis. Such overproduction of purine is further metabolised and produces more uric acid and hyperuricemia.<strong> </strong></p>\r\n<p><strong>HGPRT</strong> (<strong>Hypoxanthine guanine phosphoribosyl transferase)</strong> <strong>(Option B) </strong>is an enzyme involved in the salvage pathway. Its deficiency can lead to reduced purine salvage and increased purine nucleotide synthesis, which further catabolizes and produces more uric acid and hyperuricemia. HGPRTase deficiency can lead to <strong>Lesch-Nyhan syndrome.</strong></p>\r\n<p><strong>Phosphoribosyl amido transferase (PRAT) (Option D):</strong> This enzyme is involved in the de novo synthesis of purine nucleotides. It is abnormally active, not subject to feedback inhibition by excess nucleotides. So, increased purine synthesis, which is further catabolized and produced in more uric acid and hyperuricemia.</p>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Ammonia</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbon dioxide</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycine</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Alanine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following is an end product of pyrimidine catabolism, except</span></p>",
      "unique_key": "DT1182367",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182367,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The catabolism of the pyrimidines forms highly water-soluble products- CO2, NH3, &beta;-alanine, and &beta;-aminoisobutyrate, but not glycine.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509041027021f-4a67-40db-a7e8-8f64c6d93c1a.png\">\n<p><strong>Explanation of other options: </strong></p>\n<p><strong>Ammonia</strong> <strong>(Option A)</strong> is released during the deamination of the pyrimidine ring.</p>\n<p><strong>Carbon dioxide</strong> <strong>(Option B) </strong>is generated during the oxidative ring opening and decarboxylation steps.</p>\n<p><strong>Alanine</strong> <strong>(Option D), </strong>specifically <strong>&beta;-alanine</strong>,is  produced from uracil catabolism (not the standard &alpha;-alanine of protein metabolism).</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">ADA enzyme deficiency</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Orotate phosphoribosyl transferase enzyme deficiency</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Dihydro pyrimidine dehydrogenase enzyme deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">&beta;-hydroxybutyric aciduria occurs due to:</span></p>",
      "unique_key": "DT1182368",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182368,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Disorders of &beta;-alanine and &beta;-aminoisobutyrate metabolism arise from defects in enzymes of pyrimidine catabolism.</p>\r\n<ul>\r\n<li><strong>&beta;-Hydroxybutyric aciduria</strong> arises from total or partial deficiency of <strong>dihydropyrimidine dehydrogenase</strong>.</li>\r\n<li>It is a disorder of <strong>pyrimidine catabolism</strong>, also termed <strong>combined uraciluria-thyminuria</strong>, reflecting accumulation of upstream bases.</li>\r\n<li>This defect impairs the formation of the <strong>&beta;-amino acids</strong>-&beta;-alanine and &beta;-aminoisobutyrate-linking it to &beta;-amino acid metabolism.</li>\r\n<li><strong>Genetic</strong> cases present with serious <strong>neurologic complications</strong> due to toxic metabolite buildup.</li>\r\n<li>A <strong>nongenetic</strong> form can be induced by <strong>5-fluorouracil</strong> therapy in patients with inherently low dihydropyrimidine dehydrogenase activity.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Vitamin B12</strong> <strong>(Option A)</strong> deficiency leads to methylmalonic aciduria.</p>\r\n<p><strong>ADA</strong> (Adenosine deaminase) (<strong>Option B)</strong> enzyme deficiency can lead to SCID (Severe Combined Immunodeficiency disease), an immunological disease.</p>\r\n<p><strong>Orotate phosphoribosyl transferase enzyme</strong> <strong>deficiency</strong> <strong>(Option C) </strong>can lead to Orotic aciduria.</p>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Orotate phosphoribosyl transferase</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Dihydropyrimidine dehydrogenase</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Orotidylate decarboxylase</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose 6 phosphatase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Type II Orotic aciduria occurs due to a deficiency of the enzyme:</span></p>",
      "unique_key": "DT1182371",
      "question_audio": null,
      "question_video": null,
      "map_id": 1182371,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Type II orotic aciduria is defined by an isolated deficiency of OMP (orotidylate) decarboxylase, the second activity of UMP synthase.</li>\n<li>This block prevents conversion of OMP to UMP, causing accumulation and urinary excretion of orotic acid.</li>\n</ul>\n<p><strong>Orotic Aciduria: </strong></p>\n<ul>\n<li>Increased excretion of Orotic acid in urine</li>\n<li>Disorder of pyrimidine nucleotide synthesis</li>\n</ul>\n<p><strong>Causes:</strong></p>\n<ul>\n<li><strong>Primary orotic aciduria:</strong>\n<ul>\n<li>Inherited deficiency of enzymes involved in pyrimidine biosynthesis: UMP synthase</li>\n<li>UMP synthase is a multi-enzyme complex containing both orotate phosphoribosyl transferase and/ or orotidylate (OMP) decarboxylase activity</li>\n<li>Two types based on severity:\n<ul>\n<li><strong>Type I Orotic aciduria: </strong>Severe deficiency of both enzymes</li>\n<li><strong>Type II Orotic aciduria: </strong>Deficiency of only orotidylate (OMP) decarboxylase</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Secondary Orotic aciduria:</strong>\n<ul>\n<li><strong>Drug-induced orotic aciduria:</strong> Allopurinol &amp; 6-Azauridin: Metabolites of these drugs inhibit OMP decarboxylase</li>\n<li><strong>Ornithine transcarbamoylase deficiency</strong>: A urea cycle disorder, resulting in the accumulation of Carbamoyl Phosphate (CP) in mitochondria, which is then diverted to cytosolic overproduction of orotic acid</li>\n<li><strong>Reye's syndrome</strong>: Severely damaged mitochondria, not able to utilise carbamoyl phosphate in the formation of urea, which then diverts to cytosolic overproduction of orotic acid</li>\n</ul>\n</li>\n</ul>\n<p><strong>Clinical features:</strong></p>\n<ul>\n<li>Accumulation of orotic acid in the blood, orotic acid crystals in the urine may lead to urinary tract obstruction</li>\n<li>A defect in pyrimidine nucleotide synthesis results in inhibition of DNA and RNA synthesis, which causes megaloblastic anaemia &amp; growth retardation</li>\n</ul>\n<p><strong>Treatment: </strong></p>\n<p>Administration of Uridine: because Uridine bypasses defective enzyme steps.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509047f4c0cc6-0a6b-4e4e-8c9d-49031b8c9550.png\">\n<p><strong>Explanation of other options: </strong></p>\n<p>Type I orotic aciduria reflects a deficiency of both <strong>orotate phosphoribosyl transferase</strong> and orotidylate decarboxylase. <strong>(Option A)</strong></p>\n<p><strong>Dihydropyrimidine dehydrogenase (Option B) </strong>is an enzyme involved in pyrimidine catabolism. Its deficiency results in &beta;-hydroxybutyric aciduria.</p>\n<p><strong>Glucose 6-phosphatase (Option D) </strong>deficiency leads to Von Gierke's disease, a disease associated with glycogen metabolism.</p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}